Prof. Robert Hawkins, Consultant Medical Oncologist
Prof. Robert Hawkins
Consultant Medical Oncologist
Prof. Robert Hawkins MA, MB BS, PhD, FRCP
Consultant Medical Oncologist
Prof. Robert Hawkins
Consultant Medical Oncologist MA, MB BS, PhD, FRCP

Areas of expertise
- Kidney cancer
- Malignant melanoma
- Immunotherapy
- Chemotherapy
- Renal cancer

About Prof. Robert Hawkins
GMC number: 2921925
Year qualified: 1984
Place of primary qualification: University of London
Prof. Robert Hawkins is a Consultant Medical Oncologist at The Christie NHS Trust in Manchester. He also sees patients privately at The Christie Private Care. His specialist interests include adrenal cancer, kidney cancer, melanoma, and soft tissue cancer.
Prof. Hawkins focuses on immunotherapy as a treatment for cancer, including the delivery of high-dose interleukin-2 as a potentially curative treatment for selected patients with renal cancer. He also undertakes Phase I/II trials of immune and other biological therapies in a wider range of cancers, including gastrointestinal cancers, melanoma, B cell lymphomas, and renal cancers.
Adoptive cellular therapy is the major translational research interest of Prof. Hawkins. He leads the EU 'ATTACK' programme and the EU 'ATTRACT' training network, which links leading European researchers in the engineered T-cell field. He has established a specialist Cellular Therapy Laboratory Unit in Manchester, which currently supports trials and treatments of cellular therapy for B-cell malignancies and melanoma.
Prof. Hawkins has published widely on clinical and translational cancer research and is on several research committees. He attended medical school at Cambridge University and University College London, followed by medical oncology training at the Royal Marsden and Addenbrooke's Hospitals. He attained a PhD in antibody engineering at the MRC Laboratory of Molecular Biology in Cambridge.
Areas of expertise
- Renal cancer
- Immunotherapy
- Biomarkers
- Renal cancer
- Adrenal cancers
- GI cancers
- Cellular Therapy Melanoma
- Cell therapy
- Clinical trials
- Translational
- Medical oncology
- Biomarker research
- Melanoma cell therapy
Professional memberships


Articles by Prof. Robert Hawkins
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the uk
Stability consideration for cryopreserved starting material to facilitate large-scale production of atmps